Niall M N Fanning

Title: Inventor Spotlight: Niall M N Fanning

Introduction

Niall M N Fanning, an innovative inventor based in Raheny, Ireland, has made significant contributions to the field of pharmaceutical compositions. His dedication to advancing medical treatments has led to the development of a notable patent that addresses the need for effective infection management.

Latest Patents

Niall holds a patent for a composition titled "Nanoparticulate and controlled release compositions comprising cefditoren." This invention presents a sophisticated formulation that includes cefditoren, along with its various forms such as salts, derivatives, and prodrugs, like cefditoren pivoxil. The composition specifically targets the treatment and prevention of infections. Notably, it involves nanoparticulate particles with an effective average particle size of less than 2000 nm, optimized for improved delivery in either a pulsatile or continuous manner.

Career Highlights

Niall is currently affiliated with Alkermes Pharma Ireland Limited, where he plays a vital role in the research and development of pharmaceutical innovations. His work has not only impacted the company but has the potential to influence broader healthcare outcomes by improving drug efficacy and delivery mechanisms.

Collaborations

Throughout his career, Niall has collaborated with esteemed colleagues, including John G Devane and Paul Stark. These partnerships have fostered an environment of creativity and innovation, enhancing their collective ability to address complex challenges in the pharmaceutical field.

Conclusion

Niall M N Fanning exemplifies the spirit of innovation, combining advanced scientific understanding with practical applications to improve healthcare. His work in nanoparticulate formulations signifies a promising advancement in the treatment of infections, showcasing the critical role of inventors in shaping the future of medicine.